| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Intermittent Explosive Disorder | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| Impulse Control Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Mental Disorders | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| Fluoxetine | |||||
| Divalproex | |||||
| Placebo | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Valproic Acid | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anticonvulsants | |||||
| Antidepressive Agents | |||||
| Antidepressive Agents, Second-Generation | |||||
| Antimanic Agents | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Enzyme Inhibitors | |||||
| GABA Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Neurotransmitter Uptake Inhibitors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Serotonin Agents | |||||
| Serotonin Uptake Inhibitors | |||||
| Therapeutic Uses | |||||
| Tranquilizing Agents | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||
|
